- Home
- VIVK vs FGEN Comparison
VIVK vs FGEN Comparison
Compare VIVK & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVK
- FGEN
- Stock Information
- Founded
- VIVK 2006
- FGEN 1993
- Country
- VIVK United States
- FGEN United States
- Employees
- VIVK N/A
- FGEN N/A
- Industry
- VIVK Oilfield Services/Equipment
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- VIVK Energy
- FGEN Health Care
- Exchange
- VIVK Nasdaq
- FGEN Nasdaq
- Market Cap
- VIVK 38.4M
- FGEN 38.4M
- IPO Year
- VIVK N/A
- FGEN 2014
- Fundamental
- Price
- VIVK $0.83
- FGEN $9.50
- Analyst Decision
- VIVK
- FGEN Strong Buy
- Analyst Count
- VIVK 0
- FGEN 2
- Target Price
- VIVK N/A
- FGEN $146.50
- AVG Volume (30 Days)
- VIVK 348.9K
- FGEN 53.7K
- Earning Date
- VIVK 08-26-2025
- FGEN 08-11-2025
- Dividend Yield
- VIVK N/A
- FGEN N/A
- EPS Growth
- VIVK N/A
- FGEN N/A
- EPS
- VIVK N/A
- FGEN N/A
- Revenue
- VIVK $111,130,140.00
- FGEN $7,346,000.00
- Revenue This Year
- VIVK N/A
- FGEN N/A
- Revenue Next Year
- VIVK N/A
- FGEN N/A
- P/E Ratio
- VIVK N/A
- FGEN N/A
- Revenue Growth
- VIVK 85.84
- FGEN N/A
- 52 Week Low
- VIVK $0.55
- FGEN $4.50
- 52 Week High
- VIVK $2.05
- FGEN $21.94
- Technical
- Relative Strength Index (RSI)
- VIVK 43.37
- FGEN 68.72
- Support Level
- VIVK $0.81
- FGEN $9.05
- Resistance Level
- VIVK $1.07
- FGEN $9.94
- Average True Range (ATR)
- VIVK 0.14
- FGEN 0.58
- MACD
- VIVK -0.02
- FGEN 0.24
- Stochastic Oscillator
- VIVK 3.82
- FGEN 82.10
About VIVK Vivakor Inc.
Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services. Company have two operating business segments: Transportation logistics services; Terminaling and storage facility product and services related to oil and gas production. Majority of revenue is from Terminaling and storage segment.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.